Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.21 USD | +1.38% | +0.45% | -4.33% |
05-15 | Compugen Names David Silberman CFO | MT |
05-13 | Oramed Pharmaceuticals Inc. Announces Resignation of David Silberman as Chief Financial Officer, Effective July 12, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.33% | 88.57M | |
+48.64% | 54.63B | |
-6.44% | 39.92B | |
+37.07% | 38.82B | |
+14.28% | 26.86B | |
-11.17% | 26.22B | |
-21.40% | 18.78B | |
+25.64% | 12.21B | |
+0.96% | 12.16B | |
+27.04% | 11.94B |
- Stock Market
- Equities
- ORMP Stock
- News Oramed Pharmaceuticals Inc.
- Oramed Pharmaceuticals Inc. Announces Resignation of Avraham Gabay as Chief Financial Officer, Effective July 5, 2021